Anti-obesity Drugs Market, Global Outlook and Forecast 2022-2028

April 2022 | 76 pages | ID: A3E2DBAFF2ABEN
Market Monitor Global

Abstracts

Anti-obesity drugs are pharmacological agents that reduce or control weight. These drugs alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories. The main treatment modalities for overweight and obese individuals remain dieting and physical exercise.

This report contains market size and forecasts of Anti-obesity Drugs in global, including the following market information:

Global Anti-obesity Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Anti-obesity Drugs Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Anti-obesity Drugs companies in 2021 (%)

The global Anti-obesity Drugs market was valued at 1876.9 million in 2021 and is projected to reach US$ 5385.2 million by 2028, at a CAGR of 16.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Peripherally Acting Anti-obesity Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anti-obesity Drugs include Merck, Novo Nordisk, Pfizer, Arena Pharmaceuticals, Roche, GlaxoSmithKline, Orexigen Therapeutics, Vivus and Amylin, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-obesity Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti-obesity Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Anti-obesity Drugs Market Segment Percentages, by Type, 2021 (%)

• Peripherally Acting Anti-obesity Drugs
• Centrally Acting Anti-obesity Drugs

Global Anti-obesity Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Anti-obesity Drugs Market Segment Percentages, by Application, 2021 (%)

• Kids
• Adults

Global Anti-obesity Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Anti-obesity Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anti-obesity Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Anti-obesity Drugs revenues share in global market, 2021 (%)

Key companies Anti-obesity Drugs sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Anti-obesity Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• Novo Nordisk
• Pfizer
• Arena Pharmaceuticals
• Roche
• GlaxoSmithKline
• Orexigen Therapeutics
• Vivus
• Amylin
• Alizyme
• Boehringer Ingelheim
• Eisai

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anti-obesity Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anti-obesity Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTI-OBESITY DRUGS OVERALL MARKET SIZE

2.1 Global Anti-obesity Drugs Market Size: 2021 VS 2028
2.2 Global Anti-obesity Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Anti-obesity Drugs Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Anti-obesity Drugs Players in Global Market
3.2 Top Global Anti-obesity Drugs Companies Ranked by Revenue
3.3 Global Anti-obesity Drugs Revenue by Companies
3.4 Global Anti-obesity Drugs Sales by Companies
3.5 Global Anti-obesity Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Anti-obesity Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Anti-obesity Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-obesity Drugs Players in Global Market
  3.8.1 List of Global Tier 1 Anti-obesity Drugs Companies
  3.8.2 List of Global Tier 2 and Tier 3 Anti-obesity Drugs Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Anti-obesity Drugs Market Size Markets, 2021 & 2028
  4.1.2 Peripherally Acting Anti-obesity Drugs
  4.1.3 Centrally Acting Anti-obesity Drugs
4.2 By Type - Global Anti-obesity Drugs Revenue & Forecasts
  4.2.1 By Type - Global Anti-obesity Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Anti-obesity Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Anti-obesity Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Anti-obesity Drugs Sales & Forecasts
  4.3.1 By Type - Global Anti-obesity Drugs Sales, 2017-2022
  4.3.2 By Type - Global Anti-obesity Drugs Sales, 2023-2028
  4.3.3 By Type - Global Anti-obesity Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Anti-obesity Drugs Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anti-obesity Drugs Market Size, 2021 & 2028
  5.1.2 Kids
  5.1.3 Adults
5.2 By Application - Global Anti-obesity Drugs Revenue & Forecasts
  5.2.1 By Application - Global Anti-obesity Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Anti-obesity Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Anti-obesity Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Anti-obesity Drugs Sales & Forecasts
  5.3.1 By Application - Global Anti-obesity Drugs Sales, 2017-2022
  5.3.2 By Application - Global Anti-obesity Drugs Sales, 2023-2028
  5.3.3 By Application - Global Anti-obesity Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Anti-obesity Drugs Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Anti-obesity Drugs Market Size, 2021 & 2028
6.2 By Region - Global Anti-obesity Drugs Revenue & Forecasts
  6.2.1 By Region - Global Anti-obesity Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Anti-obesity Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Anti-obesity Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Anti-obesity Drugs Sales & Forecasts
  6.3.1 By Region - Global Anti-obesity Drugs Sales, 2017-2022
  6.3.2 By Region - Global Anti-obesity Drugs Sales, 2023-2028
  6.3.3 By Region - Global Anti-obesity Drugs Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Anti-obesity Drugs Revenue, 2017-2028
  6.4.2 By Country - North America Anti-obesity Drugs Sales, 2017-2028
  6.4.3 US Anti-obesity Drugs Market Size, 2017-2028
  6.4.4 Canada Anti-obesity Drugs Market Size, 2017-2028
  6.4.5 Mexico Anti-obesity Drugs Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Anti-obesity Drugs Revenue, 2017-2028
  6.5.2 By Country - Europe Anti-obesity Drugs Sales, 2017-2028
  6.5.3 Germany Anti-obesity Drugs Market Size, 2017-2028
  6.5.4 France Anti-obesity Drugs Market Size, 2017-2028
  6.5.5 U.K. Anti-obesity Drugs Market Size, 2017-2028
  6.5.6 Italy Anti-obesity Drugs Market Size, 2017-2028
  6.5.7 Russia Anti-obesity Drugs Market Size, 2017-2028
  6.5.8 Nordic Countries Anti-obesity Drugs Market Size, 2017-2028
  6.5.9 Benelux Anti-obesity Drugs Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Anti-obesity Drugs Revenue, 2017-2028
  6.6.2 By Region - Asia Anti-obesity Drugs Sales, 2017-2028
  6.6.3 China Anti-obesity Drugs Market Size, 2017-2028
  6.6.4 Japan Anti-obesity Drugs Market Size, 2017-2028
  6.6.5 South Korea Anti-obesity Drugs Market Size, 2017-2028
  6.6.6 Southeast Asia Anti-obesity Drugs Market Size, 2017-2028
  6.6.7 India Anti-obesity Drugs Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Anti-obesity Drugs Revenue, 2017-2028
  6.7.2 By Country - South America Anti-obesity Drugs Sales, 2017-2028
  6.7.3 Brazil Anti-obesity Drugs Market Size, 2017-2028
  6.7.4 Argentina Anti-obesity Drugs Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Anti-obesity Drugs Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Anti-obesity Drugs Sales, 2017-2028
  6.8.3 Turkey Anti-obesity Drugs Market Size, 2017-2028
  6.8.4 Israel Anti-obesity Drugs Market Size, 2017-2028
  6.8.5 Saudi Arabia Anti-obesity Drugs Market Size, 2017-2028
  6.8.6 UAE Anti-obesity Drugs Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck Anti-obesity Drugs Major Product Offerings
  7.1.4 Merck Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
  7.1.5 Merck Key News
7.2 Novo Nordisk
  7.2.1 Novo Nordisk Corporate Summary
  7.2.2 Novo Nordisk Business Overview
  7.2.3 Novo Nordisk Anti-obesity Drugs Major Product Offerings
  7.2.4 Novo Nordisk Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
  7.2.5 Novo Nordisk Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Anti-obesity Drugs Major Product Offerings
  7.3.4 Pfizer Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
  7.3.5 Pfizer Key News
7.4 Arena Pharmaceuticals
  7.4.1 Arena Pharmaceuticals Corporate Summary
  7.4.2 Arena Pharmaceuticals Business Overview
  7.4.3 Arena Pharmaceuticals Anti-obesity Drugs Major Product Offerings
  7.4.4 Arena Pharmaceuticals Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
  7.4.5 Arena Pharmaceuticals Key News
7.5 Roche
  7.5.1 Roche Corporate Summary
  7.5.2 Roche Business Overview
  7.5.3 Roche Anti-obesity Drugs Major Product Offerings
  7.5.4 Roche Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
  7.5.5 Roche Key News
7.6 GlaxoSmithKline
  7.6.1 GlaxoSmithKline Corporate Summary
  7.6.2 GlaxoSmithKline Business Overview
  7.6.3 GlaxoSmithKline Anti-obesity Drugs Major Product Offerings
  7.6.4 GlaxoSmithKline Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
  7.6.5 GlaxoSmithKline Key News
7.7 Orexigen Therapeutics
  7.7.1 Orexigen Therapeutics Corporate Summary
  7.7.2 Orexigen Therapeutics Business Overview
  7.7.3 Orexigen Therapeutics Anti-obesity Drugs Major Product Offerings
  7.7.4 Orexigen Therapeutics Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
  7.7.5 Orexigen Therapeutics Key News
7.8 Vivus
  7.8.1 Vivus Corporate Summary
  7.8.2 Vivus Business Overview
  7.8.3 Vivus Anti-obesity Drugs Major Product Offerings
  7.8.4 Vivus Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
  7.8.5 Vivus Key News
7.9 Amylin
  7.9.1 Amylin Corporate Summary
  7.9.2 Amylin Business Overview
  7.9.3 Amylin Anti-obesity Drugs Major Product Offerings
  7.9.4 Amylin Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
  7.9.5 Amylin Key News
7.10 Alizyme
  7.10.1 Alizyme Corporate Summary
  7.10.2 Alizyme Business Overview
  7.10.3 Alizyme Anti-obesity Drugs Major Product Offerings
  7.10.4 Alizyme Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
  7.10.5 Alizyme Key News
7.11 Boehringer Ingelheim
  7.11.1 Boehringer Ingelheim Corporate Summary
  7.11.2 Boehringer Ingelheim Anti-obesity Drugs Business Overview
  7.11.3 Boehringer Ingelheim Anti-obesity Drugs Major Product Offerings
  7.11.4 Boehringer Ingelheim Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
  7.11.5 Boehringer Ingelheim Key News
7.12 Eisai
  7.12.1 Eisai Corporate Summary
  7.12.2 Eisai Anti-obesity Drugs Business Overview
  7.12.3 Eisai Anti-obesity Drugs Major Product Offerings
  7.12.4 Eisai Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
  7.12.5 Eisai Key News

8 GLOBAL ANTI-OBESITY DRUGS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Anti-obesity Drugs Production Capacity, 2017-2028
8.2 Anti-obesity Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-obesity Drugs Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ANTI-OBESITY DRUGS SUPPLY CHAIN ANALYSIS

10.1 Anti-obesity Drugs Industry Value Chain
10.2 Anti-obesity Drugs Upstream Market
10.3 Anti-obesity Drugs Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Anti-obesity Drugs Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Anti-obesity Drugs in Global Market
Table 2. Top Anti-obesity Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Anti-obesity Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Anti-obesity Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Anti-obesity Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Anti-obesity Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Anti-obesity Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Anti-obesity Drugs Product Type
Table 9. List of Global Tier 1 Anti-obesity Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-obesity Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anti-obesity Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Anti-obesity Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Anti-obesity Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Anti-obesity Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Anti-obesity Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Anti-obesity Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Anti-obesity Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Anti-obesity Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Anti-obesity Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Anti-obesity Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Anti-obesity Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Anti-obesity Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Anti-obesity Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Anti-obesity Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Anti-obesity Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Anti-obesity Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Anti-obesity Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Anti-obesity Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Anti-obesity Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Anti-obesity Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Anti-obesity Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Anti-obesity Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Anti-obesity Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Anti-obesity Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Anti-obesity Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Anti-obesity Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Anti-obesity Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Anti-obesity Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Anti-obesity Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Anti-obesity Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Anti-obesity Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Anti-obesity Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Anti-obesity Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Anti-obesity Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Anti-obesity Drugs Sales, (K Units), 2023-2028
Table 46. Merck Corporate Summary
Table 47. Merck Anti-obesity Drugs Product Offerings
Table 48. Merck Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Novo Nordisk Corporate Summary
Table 50. Novo Nordisk Anti-obesity Drugs Product Offerings
Table 51. Novo Nordisk Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Anti-obesity Drugs Product Offerings
Table 54. Pfizer Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Arena Pharmaceuticals Corporate Summary
Table 56. Arena Pharmaceuticals Anti-obesity Drugs Product Offerings
Table 57. Arena Pharmaceuticals Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Roche Corporate Summary
Table 59. Roche Anti-obesity Drugs Product Offerings
Table 60. Roche Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. GlaxoSmithKline Corporate Summary
Table 62. GlaxoSmithKline Anti-obesity Drugs Product Offerings
Table 63. GlaxoSmithKline Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Orexigen Therapeutics Corporate Summary
Table 65. Orexigen Therapeutics Anti-obesity Drugs Product Offerings
Table 66. Orexigen Therapeutics Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Vivus Corporate Summary
Table 68. Vivus Anti-obesity Drugs Product Offerings
Table 69. Vivus Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Amylin Corporate Summary
Table 71. Amylin Anti-obesity Drugs Product Offerings
Table 72. Amylin Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Alizyme Corporate Summary
Table 74. Alizyme Anti-obesity Drugs Product Offerings
Table 75. Alizyme Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Boehringer Ingelheim Corporate Summary
Table 77. Boehringer Ingelheim Anti-obesity Drugs Product Offerings
Table 78. Boehringer Ingelheim Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Eisai Corporate Summary
Table 80. Eisai Anti-obesity Drugs Product Offerings
Table 81. Eisai Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Anti-obesity Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 83. Global Anti-obesity Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global Anti-obesity Drugs Production by Region, 2017-2022 (K Units)
Table 85. Global Anti-obesity Drugs Production by Region, 2023-2028 (K Units)
Table 86. Anti-obesity Drugs Market Opportunities & Trends in Global Market
Table 87. Anti-obesity Drugs Market Drivers in Global Market
Table 88. Anti-obesity Drugs Market Restraints in Global Market
Table 89. Anti-obesity Drugs Raw Materials
Table 90. Anti-obesity Drugs Raw Materials Suppliers in Global Market
Table 91. Typical Anti-obesity Drugs Downstream
Table 92. Anti-obesity Drugs Downstream Clients in Global Market
Table 93. Anti-obesity Drugs Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Anti-obesity Drugs Segment by Type
Figure 2. Anti-obesity Drugs Segment by Application
Figure 3. Global Anti-obesity Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anti-obesity Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti-obesity Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Anti-obesity Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-obesity Drugs Revenue in 2021
Figure 9. By Type - Global Anti-obesity Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Anti-obesity Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Anti-obesity Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Anti-obesity Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Anti-obesity Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Anti-obesity Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Anti-obesity Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Anti-obesity Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Anti-obesity Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Anti-obesity Drugs Sales Market Share, 2017-2028
Figure 19. US Anti-obesity Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Anti-obesity Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Anti-obesity Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Anti-obesity Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Anti-obesity Drugs Sales Market Share, 2017-2028
Figure 24. Germany Anti-obesity Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Anti-obesity Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Anti-obesity Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Anti-obesity Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Anti-obesity Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Anti-obesity Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Anti-obesity Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Anti-obesity Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Anti-obesity Drugs Sales Market Share, 2017-2028
Figure 33. China Anti-obesity Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Anti-obesity Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Anti-obesity Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Anti-obesity Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Anti-obesity Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Anti-obesity Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Anti-obesity Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Anti-obesity Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Anti-obesity Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Anti-obesity Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Anti-obesity Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Anti-obesity Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Anti-obesity Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Anti-obesity Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Anti-obesity Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Anti-obesity Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Anti-obesity Drugs by Region, 2021 VS 2028
Figure 50. Anti-obesity Drugs Industry Value Chain
Figure 51. Marketing Channels